Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03336281
What this trial is testing

Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab

Who this might be right for
Psoriatic Arthritis
Janssen Cilag S.A.S. 221
Large-scale testing (Phase 3)Study completedNCT02052609
What this trial is testing

Clinical Study of KHK 4827

Who this might be right for
Psoriasis VulgarisPsoriatic ArthritisPustular; Psoriasis, Palmaris Et Plantaris+1 more
Kyowa Kirin Co., Ltd. 155
Large-scale testing (Phase 3)Study completedNCT01961609
What this trial is testing

Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 235
Testing effectiveness (Phase 2)Study completedNCT05188521
What this trial is testing

Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus

Who this might be right for
Cutaneous Lichen Planus
Aaron R. Mangold 12
Testing effectiveness (Phase 2)Study completedNCT01283698
What this trial is testing

Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis

Who this might be right for
Psoriasis
Almirall, S.A. 20
Not applicableLooking for participantsNCT03248284
What this trial is testing

Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons

Who this might be right for
Psoriatic ArthritisEnthesitis
Odense University Hospital 30
Early research (Phase 1)Study completedNCT02763969
What this trial is testing

Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 357
Not applicableLooking for participantsNCT07736651
What this trial is testing

Anti Inflammatory Diet With Physical Therapy on Psoriasis

Who this might be right for
Psoriasis
Mahmoud Usama Mahmoud Ahmed 60
Not applicableStudy completedNCT05065762
What this trial is testing

Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment

Who this might be right for
Psoriasis
Bristol-Myers Squibb 232
Post-approval studies (Phase 4)Study completedNCT00852761
What this trial is testing

Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis

Who this might be right for
Plaque-Type Psoriasis
Stiefel, a GSK Company 34
Testing effectiveness (Phase 2)Study completedNCT01610596
What this trial is testing

Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Psoriasis
Therapeutics, Inc. 72
Post-approval studies (Phase 4)Study completedNCT03942042
What this trial is testing

Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis

Who this might be right for
Generalized Pustular PsoriasisErythrodermic Psoriasis
Eli Lilly and Company 12
Testing effectiveness (Phase 2)Study completedNCT03448081
What this trial is testing

Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene

Who this might be right for
PruritusPsoriasis
Sienna Biopharmaceuticals 73
Testing effectiveness (Phase 2)Study completedNCT04207801
What this trial is testing

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Aurigene Discovery Technologies Limited 90
Large-scale testing (Phase 3)Study completedNCT02196701
What this trial is testing

Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study

Who this might be right for
Psoriasis
AbbVie 46
Not applicableActive Not RecruitingNCT06905028
What this trial is testing

Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)

Who this might be right for
Psoriasis ArthritisPsoriasis (PsO)
Charite University, Berlin, Germany 30
Not applicableStudy completedNCT04523077
What this trial is testing

Association of Oral Lichen Planus and Thyroid Disease

Who this might be right for
Oral Lichen PlanusThyroid Diseases
University of Zagreb 50
Large-scale testing (Phase 3)WithdrawnNCT01815723
What this trial is testing

Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Forward-Pharma GmbH
Testing effectiveness (Phase 2)Study completedNCT00687362
What this trial is testing

Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 22
Not applicableWithdrawnNCT04799990
What this trial is testing

Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting

Who this might be right for
Psoriasis
AbbVie
Next Page